Bellon Christine 4
4 · Beam Therapeutics Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Bellon Christine
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-31$24.40/sh+55,000$1,342,000→ 55,000 totalExercise: $24.40Exp: 2034-01-31→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date